Telix Pharmaceuticals Limited Description Of Growth Rate Used To Extrapolate Cash Flow Projections
Telix Pharmaceuticals Limited (TLPPF) had Description Of Growth Rate Used To Extrapolate Cash Flow Projections of 5.00% as of 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Notes
ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections · last filed 2026-02-20
- 2025-12-31: Description Of Growth Rate Used To Extrapolate Cash Flow Projections 5.00%.
- 2024-12-31: Description Of Growth Rate Used To Extrapolate Cash Flow Projections 5.00%.
| Period end | Description Of Growth Rate Used To Extrapolate Cash Flow Projections |
|---|---|
| 2025-12-31 | 5.00% 20-F · filed 2026-02-20 |
| 2024-12-31 | 5.00% 20-F · filed 2026-02-20 |